D086

DRUG3 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

HyperlipidemiasHypertensionHypertensive Patients With DyslipidemiaPrimary Hypercholesterolemia

Phase 1

Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

CompletedNCT03017950

Chong Kun Dang PharmaceuticalHyperlipidemias, Hypertension

Start: 2016-12-31End: 2017-05-31Updated: 2017-07-21

Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

CompletedNCT03583905

Chong Kun Dang PharmaceuticalHypertensive Patients With Dyslipidemia

Start: 2018-04-04End: 2019-07-17Updated: 2019-07-24

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia

Chong Kun Dang PharmaceuticalPrimary Hypercholesterolemia

Start: 2022-11-24End: 2023-06-30Target: 228Updated: 2022-12-20